Navigation Links
Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
Date:8/19/2007

epted by the market, including the risk that these products will not be competitive with products offered by other companies; and (2) other factors that might be described from time to time in Applera's filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and Applera does not undertake any duty to update this information, including any forward-looking statements, unless required by law.

About Abbott's Molecular Diagnostics Business

Abbott Molecular, a division of Abbott based in Des Plaines, Ill., is an emerging leader in molecular diagnostics -- the analysis of DNA, RNA and proteins at the molecular level. Abbott Molecular's instruments and tests provide physicians with critical information based on the early detection of pathogens and subtle, but key changes in patients' genes and chromosomes. They help physicians diagnose disease and infections earlier, select appropriate therapies and monitor disease progression. In addition to the RealTime HIV-1 viral load test and the Abbott m2000, Abbott Molecular's portfolio of products also includes innovative genomic tests for chromosome changes associated with congenital disorders and cancer, including the PathVysion(R) HER-2 DNA Probe Kit, a test used to help select women with breast cancer who could benefit from Herceptin(R) therapy, and UroVysion(TM), which detects genetic changes in bladder cells for aiding in the diagnosis of bladder cancer in patients with hematuria (blood in the urine) and for monitoring bladder cancer recurrence.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available at the company's Web site
'/>"/>

SOURCE Abbott

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
8. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
9. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
10. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
11. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ... development and commercialization of innovative therapies for the ... that it will release Second Quarter financial results ... AcelRx management will host an investment-community conference call ... Time) on Aug 3rd, 2015 to discuss the ...
(Date:7/29/2015)... VIEW, Calif. , July 29, 2015  Efforts ... the growth strategy of pharmaceutical firms in ... . The realization is that an effective working capital ... pricing pressures and patent cliffs. Big pharma companies expect ... returns. Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO ...
(Date:7/29/2015)... ATLANTA , July 29, 2015 Legal-Bay LLC, ... Judge Joseph Goodwin in the Southern District of ... altered the single trial that was initially set to start ... claims from women, but new plaintiffs were added and now ... back to December 7 th , according to an article ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 3AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 4Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3
... Reportlinker.com announces that a new ... its catalogue: X-Ray ... Landscape and Market Forecasts to 2017 ... X-Ray Systems - Global ...
... Nov. 22, 2011 Reportlinker.com announces ... is available in its catalogue: ... Pipeline Analysis, Competitive Landscape and Market ... http://www.reportlinker.com/p0685953/MRI-Systems---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging MRI ...
Cached Medicine Technology:X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 13MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12
(Date:7/29/2015)... ... July 29, 2015 , ... CrossFit 269, offering a nationally ... Kalamazoo Strength & Conditioning. , The name change coincides with the release of ... training center over the past three years,” according to Jack Kelly, the center’s ...
(Date:7/29/2015)... ... July 29, 2015 , ... Today marks a significant achievement in bringing new ... companies and is led by a group of experienced investors, has tapped into an ... their dollars to be a part of the fund. The Sofia Fund II ...
(Date:7/29/2015)... ... ... July is National UV Awareness Month, and in honor of this month, Dr. Melda Isaac ... skin from the sun, as well as how to best treat existing sun damage. Sun ... common skin conditions in America. Many people do not protect their skin sufficiently when going ...
(Date:7/29/2015)... ... July 29, 2015 , ... Stealth Therapeutics Inc. announced ... Study for the Invisiport at Wheaton Franciscan Healthcare in Milwaukee, Wis. The Invisiport ... less invasive, patient-friendly alternative to traditional chest ports and peripherally inserted central catheters ...
(Date:7/29/2015)... ... July 29, 2015 , ... Toronto native Douglas James Cottrell, ... Cottrell has been making predictions about the economy, politics, social issues, as well ... prognostications. He warns that extreme weather conditions and increased earthquake / volcanic activity ...
Breaking Medicine News(10 mins):Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:Sofia Fund Surpasses Investor Goals 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2
... International,(Nasdaq: PRAI ), a leading clinical research ... Stansfield as Executive Vice President,with responsibility for Product ... Executive Vice President, will continue,to have responsibility for ... very pleased to continue the process of strengthening ...
... foods have a reputation for being full of flavor. ... for generations are,being prepared now in ways that can ... with high-calorie ingredients that,are fried or full of salt ... foods high in fat and calories can place people,at ...
... Clinical trial on injection lipolysis treatment to begin ... Aesthetic Surgery,Education and Research Foundation (ASERF) announced today ... and Drug Administration to initiate a,clinical trial investigating ... lipolysis treatment. Treatments most properly called injection ...
... California Veterinary Medical Association Urges Home and Pet Owners to ... Follow Guidelines to Prevent a Surprise Attack, ... mountain lion at their doorstep, but recent encounters between,homeowners and ... calm pet owners, fears with tips on what to,do to ...
... Graff and colleagues from Eli Lilly and Company has demonstrated ... model of human tumors and has spawned clinical trials to ... As highlighted in the accompanying commentary by Celeste Simon and ... is as effective in clinical trials as it was in ...
... (ADHD) is no longer diagnosed just,in schoolchildren. ADHD has ... ages 3 to 5. Researchers have now begun to ... reports the,September 2007 issue of the Harvard Mental Health ... hard to tell whether certain behaviors,represent a real problem ...
Cached Medicine News:Health News:PRA International Adds Dr. Susan Stansfield as Executive Vice President 2Health News:PRA International Adds Dr. Susan Stansfield as Executive Vice President 3Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 2Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 3Health News:Investigational New Drug Application for 'Fat Melting' Injections Cleared by the FDA 2Health News:Wildlife Sightings on the Rise in California 2Health News:Wildlife Sightings on the Rise in California 3Health News:It's a knock out: eIF4E-specific anti-sense oligonucleotides knock down cancer 2Health News:How Best to Treat Preschoolers With ADHD? The Harvard Mental Health Letter Discusses the Options 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: